Language: English
Sickle cell disease (SCD) is a complex disorder that requires multiple players working to improve outcomes in the short- and long-term. Learn below how three entities – the SCD Coalition (SCDC); American Society of Hematology (ASH); and the National Academies of Science, Engineering, and Medicine (NASEM) – are tracking progress and strategizing to conquer SCD.
THE SCD COALITION IS TAKING A MULTI-FACETED APPROACH TO TACKLE SICKLE CELL THROUGH ITS VARIOUS SUBCOMMITTEES.
Learn More Download the PDF VersionOn a biennial basis, ASH surveys the sickle cell stakeholder community and publishes a report card on the current state of SCD.
Learn More
In 2020, NASEM released a pivotal report entitled, "Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action."
Learn More
